Cutaneous leishmaniasis. Cutaneous leishmaniasis
Conditions
Interventions
Intervention 1: Intervention group 2: The other injury is subjected to laser treatments (AlexandritLtroni, Nd-YAG, and flow index of 220 J). Intervention 2: Intervention group 2: To one of the injurie
Treatment - Other
Treatment - Drugs
Intervention group 2: The other injury is subjected to laser treatments (AlexandritLtroni, Nd-YAG, and flow index of 220 J).
Intervention group 2: To one of the injuries, Meglumine antimony is injected using a 1 cc insulin syringe. The maximum injection amount in each session is 1-2 cc. The injection is repeated weekly un
Sponsors
Vice Chancellor for Research of Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Being 5 to 55 years of age; having at least two leishmanial injuries (leishmaniasis is defined as having a clinical injury according to Cutaneous leishmaniasis along with positive smear test regarding leishmanial body confirmed by a pathologist. Exclusion criteria:Being pregnant or nursing; receiving any prior treatments (including medical or cryotherapy or laser or other destructive methods).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete improvement of the injury. Timepoint: At the end of every session, 10 weeks after start of treatment, and 3 months after improvement. Method of measurement: Measuring the induration and the size of the injury. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Jad Babai
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed